跳至主要内容
临床试验/NCT07273513
NCT07273513尚未招募不适用

"Smart Family Doctor" Assisted Comprehensive Management of Secondary Prevention Among Post Revascularization Patients

China National Center for Cardiovascular Diseases0 个研究点目标入组 951 人开始时间: 2026年1月15日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
951
主要终点
The control rates of hypertension, diabetes and hyperlipidemia

研究概览

简要总结

This study aims to evaluate the effect of an AI-assisted "Smart family doctor" digital health management tool on improving the control rates of hypertension, diabetes, and dyslipidemia in post-revascularization patients. A randomized controlled trial design will be used, involving approximately 10-20 hospitals and 951 participants. Eligible participants are adults aged between 18 and 80 years, post-CABG or post-PCI patients with hypertension, diabetes, and dyslipidemia.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

盲法说明

Data manager and statistician.

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 18-80 years.
  • Underwent CABG or PCI more than 3 months prior and have concurrent hypertension, diabetes, and dyslipidemia.
  • At least one of the following criteria is meet:
  • Systolic blood pressure no less than 130 mmHg or diastolic blood pressure no less than 80 mmHg
  • HbA1c no less than 7%
  • LDL-C no less than 1.4 mmol/L
  • Signed informed consent.

排除标准

  • History of heart failure or severe arrhythmias.
  • Presence of other severe underlying conditions such as cancer or liver and kidney insufficiency.
  • Pregnancy, lactation, or plans for pregnancy within the next year.
  • Cognitive, communication impairments, or limitations in daily activities.
  • Unable to use smartphone.

结局指标

主要结局

The control rates of hypertension, diabetes and hyperlipidemia

时间窗: 6-month

All cretria are meet: 1) Systolic blood pressure less than 130 mmHg and diastolic blood pressure less than 80 mmHg. 2) HbA1c less than 7%. 3) LDL-C less than 1.4 mmol/L.

次要结局

  • Blood Pressure Control Rate(6-month)
  • Blood lipid Control Rate(6-month)
  • Triglycerides(6-month)
  • Blood Pressure Control Rate(6-month)
  • Blood glucose Control Rate(6-month)
  • Blood lipid Control Rate(6-month)
  • Systolic blood pressure(6-month)
  • Diastolic blood pressure(6-month)
  • Fasting blood glucose(6-month)
  • HbA1c(6-month)
  • Total cholesterol(6-month)
  • LDL-C(6-month)
  • HDL-C(6-month)
  • Triglycerides(6-month)
  • Medication adherence (4-item Morisky Medication-Taking Adherence Scale)(6-month)
  • Coronary artery disease-related quality of life (the Seattle Angina Questionnaire)(6-month)
  • Smoking Rate(6-month)

研究者

发起方
China National Center for Cardiovascular Diseases
申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Xin Yuan

Professor

China National Center for Cardiovascular Diseases

相似试验